Finished
Use of Human Dehydrated Amnion/Chorion (DHACM) Allograft in Partial Nephrectomy
NCT03323021 · MiMedx Group, Inc. · Updated 13 Nov 2020
- What is being tested
- Dehydrated human amnion/chorion membrane; Standard of Care
- For
- Partial Nephrectomy; Kidney Cancer; Renal Function Aggravated
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 18 years and older. About 61 people. The full rules are on the registry page.
- Where
- United States
- When
- Starts or started 23 May 2017, ends 21 Feb 2019. Registered 26 Oct 2017.
- Results
- None posted yet.
In the researchers' words
After partial nephrectomy, kidney function decreases by about 10% overall and by about 20% in the operated kidney. This is primarily due to the loss of healthy parenchymal volume during resection of the tumor. In an effort to preserve and regenerate healthy parenchyma during the procedure and ultimately renal function after partial nephrectomy, the single center double arm single-blinded randomized screening clinical trial will evaluate the ability of human amnion/chorion allograft to facilitate the recovery of renal function following robotic partial nephrectomy.
Sites
- The Mount Sinai HospitalNew York, New York, United States